Microglial cells are activated by Aß deposits, which may initially appear as a protective phenotype. Continuation of Aß deposition reduces the efficiency of microglial cells, which leads to neuroinflammation. The colocalization of Aβ, tau, and activated microglia in the brain potentiates tau propagation. This suggests that Aβ and microglial activations are two partially independent processes that converge and lead to neocortical tau pathology. The majority of studies that have been carried out in vitro and in murine models of ageing and AD suggest that neuroinflammation is a key characteristic of AD aetiology. However, human studies of the mechanisms of neuroinflammation are limited due to the early stage of development, or lack of clinical validation of relevant biomarkers.
Read more about neuroinflammation in Alzheimer’s disease
Related content
Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.
Dementia is an umbrella term used to describe a state where an individual has lost the ability to carry out daily life activities independently because of cognitive impairment that is not due to an underlying psychiatric condition. Alzheimer’s disease (AD) refers to the abnormal presence of Aβ and tau proteins, which define AD among many other neurodegenerative diseases. Dementia -including dementia due to AD- is likely to be underestimated because of underdiagnosis and misdiagnosis.